Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.

Ratner LD, Gonzalez B, Ahtiainen P, Di Giorgio NP, Poutanen M, Calandra RS, Huhtaniemi IT, Rulli SB.

Endocrinology. 2012 Dec;153(12):5980-92. doi: 10.1210/en.2012-1393. Epub 2012 Nov 1.

2.

Genetically modified mouse models addressing gonadotropin function.

Ratner LD, Rulli SB, Huhtaniemi IT.

Reprod Biol. 2014 Mar;14(1):9-15. doi: 10.1016/j.repbio.2013.12.001. Epub 2013 Dec 25. Review.

PMID:
24607250
3.

Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.

Matzuk MM, DeMayo FJ, Hadsell LA, Kumar TR.

Biol Reprod. 2003 Jul;69(1):338-46. Epub 2003 Apr 2.

4.

Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin.

Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I.

Endocrinology. 2002 Oct;143(10):4084-95.

PMID:
12239120
5.

Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.

Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, Takano K, Izumi S, Okada Y, Hori T.

J Clin Endocrinol Metab. 2010 Jun;95(6):2672-9. doi: 10.1210/jc.2009-2605. Epub 2010 Mar 31.

PMID:
20357175
6.

New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline.

Moro M, Inada Y, Kojima M, Miyata H, Komatsu H, Torii R.

Eur J Pharmacol. 1999 Feb 26;368(1):57-66.

PMID:
10096770
7.

The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.

Bachelot A, Carré N, Mialon O, Matelot M, Servel N, Monget P, Ahtiainen P, Huhtaniemi I, Binart N.

Am J Physiol Endocrinol Metab. 2013 Oct 1;305(7):E845-52. doi: 10.1152/ajpendo.00243.2013. Epub 2013 Aug 6.

8.

A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.

Motazedian S, Babakhani L, Fereshtehnejad SM, Mojthahedi K.

Indian J Med Res. 2010 May;131:670-4.

PMID:
20516539
9.

[Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].

Shi YH, Sheng Y, Chen ZJ, Yan JH, Gao Q, Liu H, Ma ZX.

Zhonghua Fu Chan Ke Za Zhi. 2008 Apr;43(4):251-3. Chinese.

PMID:
18843962
10.

Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.

Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A.

J Clin Endocrinol Metab. 1999 Jul;84(7):2518-22.

PMID:
10404830
11.
14.

Hyperprolactinemia: pathophysiology and management.

Verhelst J, Abs R.

Treat Endocrinol. 2003;2(1):23-32. Review.

PMID:
15871552
15.

Human chorionic gonadotropin (hCG) in the secretome of cultured embryos: hyperglycosylated hCG and hCG-free beta subunit are potential markers for infertility management and treatment.

Butler SA, Luttoo J, Freire MO, Abban TK, Borrelli PT, Iles RK.

Reprod Sci. 2013 Sep;20(9):1038-45. doi: 10.1177/1933719112472739. Epub 2013 Feb 25.

PMID:
23439616
16.

[The response of ovarian function to HMG-HCG and bromocriptine therapies in hyperprolactinemic patients].

Matsuoka M, Imura H, Aso T, Okuda K.

Nihon Naibunpi Gakkai Zasshi. 1984 May 20;60(5):647-58. Japanese.

PMID:
6436078
18.

Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine.

De Rosa M, Colao A, Di Sarno A, Ferone D, Landi ML, Zarrilli S, Paesano L, Merola B, Lombardi G.

Eur J Endocrinol. 1998 Mar;138(3):286-93.

19.

Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin.

Rulli SB, Ahtiainen P, Mäkelä S, Toppari J, Poutanen M, Huhtaniemi I.

Endocrinology. 2003 Nov;144(11):4980-90. Epub 2003 Jul 31.

PMID:
12960071
20.

Hyperprolactinemia.

Biller BM.

Int J Fertil Womens Med. 1999 Mar-Apr;44(2):74-7. Review.

PMID:
10338264
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk